Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement

Y Aoyama1, T Yamane, M Hino

  • 1Department of Clinical Hematology, Osaka City University Medical School, 1-4-3, Asahimachi, Abeno-ku, Osaka-shi, Osaka, 545-8586 Japan.

Annals of Hematology
|January 18, 2002
PubMed

Insights

This study reports a rare case of T-cell lymphoblastic leukemia in a 79-year-old man. The aggressive leukemia showed a poor prognosis, relapsing early despite initial chemotherapy.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • T-cell acute lymphoblastic leukemia (T-ALL) is a rare and aggressive hematologic malignancy.
  • Accurate immunophenotypic and genotypic characterization is crucial for diagnosis and classification.

Observation:

  • A 79-year-old Japanese male presented with dyspnea, exanthema, hepatosplenomegaly, and lymphadenopathy.
  • Peripheral blood revealed abnormal lymphoblastic cells with specific immunophenotypic markers (CD2+, CD4+, CD56+, HLA-DR+).
  • Genotypic analysis showed T cell receptor (TCR) gamma chain rearrangement exclusively.

Findings:

  • The patient was diagnosed with a rare T-ALL subtype.
  • Despite initial positive response to chemotherapy, the disease exhibited early relapse.
  • The patient succumbed to the disease within 6 months of diagnosis.

Implications:

  • This case highlights the aggressive nature and poor prognosis of certain T-ALL subtypes, even with treatment.
  • Emphasizes the importance of comprehensive immunophenotypic and genotypic analysis for diagnosing and managing rare hematologic malignancies.
  • Contributes to understanding the clinical spectrum and outcomes of T-cell lymphoblastic leukemia.

Related Concept Videos